Document:

Exhibit
10.2

 

THE
ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS NOTE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE
OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION
OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED
UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT.

 

	Principal
    Amount: U.S. $774,202.00	Issue
    Date: March 31, 2020

 

PROMISSORY
NOTE

 

FOR
VALUE RECEIVED, Ngen Technologies Holding Corp., a Nevada corporation (hereinafter called the “Borrower”), hereby
promises to pay to the order of Santa Monica Venture Finance, Inc., a California corporation or registered assigns (the “Holder”)
the sum of U.S. $774,202.00 (the “Principal Amount”) together with any interest as set forth herein, on the first
annual anniversary of the Issue Date as set forth above (the “Maturity Date”), and to pay interest on the unpaid principal
balance as set forth herein hereof from the date hereof (the “Issue Date”) until the same becomes due and payable,
whether at maturity or upon acceleration or by prepayment or otherwise. All payments shall be made at such address as the Holder
shall hereafter give to the Borrower by written notice made in accordance with the provisions of this Note. Whenever any amount
expressed to be due by the terms of this Note is due on any day which is not a business day, the same shall instead be due on
the next succeeding day which is a business day and, in the case of any interest payment date which is not the date on which this
Note is paid in full, the extension of the due date thereof shall not be taken into account for purposes of determining the amount
of interest due on such date. As used in this Note, the term “business day” shall mean any day other than a Saturday,
Sunday or a day on which commercial banks in the city of New York, New York are authorized or required by law or executive order
to remain closed. Each capitalized term used herein, and not otherwise defined, shall have the meaning ascribed thereto in that
certain Restructuring, Settlement and Release Agreement between the Borrower, the Holder and the other parties thereto, dated
the date hereof, pursuant to which this Note was originally issued (the “Purchase Agreement”).

 

This
Note is free from all taxes, liens, claims and encumbrances with respect to the issue thereof and shall not be subject to preemptive
rights or other similar rights of shareholders of the Borrower and will not impose personal liability upon the holder thereof.

 

The
following terms shall apply to this Note:

 

Article
I. PAYMENT TERMS

 

Section
1.01 Interest Rate. This Note shall bear interest at the rate of 18% per annum, simple interest. Interest shall
commence accruing on the Issue Date and shall be computed on the basis of a 365-day year.

 

    	 	1	 

     

    

 

Section
1.02 Payments.  Subject to the other provisions of this Note, the Principal
Amount and all accrued and unpaid interest on this Note shall be due and payable in full on the earlier of: (i) the Maturity Date,
or (ii) the date on which a Change in Control (as defined below) of the Company occurs. For purposes herein, a “Change of
Control” shall be deemed to have occurred if, after the Issue Date, there shall have occurred
any of the following:

 

	 	(i)	a
    complete dissolution or liquidation of the Company, or similar occurrence;
	 	 	 
	 	(ii)	the
    consummation of a merger, consolidation, acquisition, separation, reorganization, or similar occurrence, in a single transaction
    or a series of related transactions, where the Company is not the surviving entity or where the shareholders of the Company
    immediately prior to the consummation of such transaction do not continue to hold at least a majority of the voting power
    of the Company following the consummation of such transaction; or
	 	 	 
	 	(iii)	a
    sale or transfer of all or substantially all of the assets of the Company, each in a single transaction or a series of related
    transactions.

 

Section
1.03 Prepayment. Notwithstanding the foregoing, the Borrower may prepay all or any portion of the Principal Amount and
any accrued and unpaid interest and any and all other amounts that may be due and payable to the Holder hereunder at any time.

 

Article
II. EVENTS OF DEFAULT

 

In
addition to the other “Events of Default” as set forth herein, if any of the events in Section 2.01 through Section
2.08, inclusive, occur, such event shall be an “Event of Default” hereunder:

 

Section
2.01 Failure to Pay Principal or Interest. The Borrower fails to pay the principal hereof or interest thereon when due
on this Note, whether at maturity, upon acceleration or otherwise, following a five (5) day cure period.

 

Section
2.02 Breach of Covenants. The Borrower breaches any covenant or other material term
or condition contained in this Note or in any collateral documents, including but not limited to the Restructuring Agreement,
or in any other agreements, promissory notes, or contracts between the Borrower and any of its Affiliates, on the one hand, and
the Holder or any of its Affiliates, on the other hand, and such breach continues for a period of ten (10) days after written
notice thereof to the Borrower from the Holder.

 

Section
2.03 Breach of Representations and Warranties. Any representation or warranty of the
Borrower made herein or in any agreement, statement or certificate given in writing pursuant hereto or in connection herewith
(including, without limitation, the Restructuring Agreement), shall be false or misleading in any material respect when made and
the breach of which has (or with the passage of time will have) a material adverse effect on the rights of the Holder with respect
to this Note or the Restructuring Agreement.

 

Section
2.04 Receiver or Trustee. The Borrower or any subsidiary of the Borrower shall make
an assignment for the benefit of creditors, or apply for or consent to the appointment of a receiver or trustee for it or for
a substantial part of its property or business, or such a receiver or trustee shall otherwise be appointed.

 

Section
2.05 Bankruptcy. Bankruptcy, insolvency, reorganization or liquidation proceedings
or other proceedings, voluntary or involuntary, for relief under any bankruptcy law or any law for the relief of debtors shall
be instituted by or against the Borrower or any subsidiary of the Borrower.

 

Section
2.06 Delisting of Common Stock. The Borrower shall fail to maintain the listing of
the Common Stock on at least one of the OTC Markets or an equivalent replacement exchange, the Nasdaq National Market, the Nasdaq
SmallCap Market, the New York Stock Exchange, or the American Stock Exchange.

 

    	 	2	 

     

    

 

Section
2.07 Liquidation. Any dissolution, liquidation, or winding up of Borrower or any substantial
portion of its business.

 

Section
2.08 Cessation of Operations. Any cessation of operations by Borrower or Borrower admits
it is otherwise generally unable to pay its debts as such debts become due, provided, however, that any disclosure of the Borrower’s
ability to continue as a “going concern” shall not be an admission that the Borrower cannot pay its debts as they
become due.

 

Section
2.09 Consequences of Event of Default. Upon the occurrence of any Event of Default, exercisable through the delivery
of written notice to the Borrower by such Holders (the “Default Notice”), this Note shall become immediately due
and payable and the Borrower shall pay to the Holder, in full satisfaction of its obligations hereunder, an amount equal to
the then outstanding principal amount of this Note plus accrued and unpaid interest on the unpaid principal amount of this
Note, and all other amounts payable hereunder shall immediately become due and payable, all without demand, presentment or
notice, all of which hereby are expressly waived, together with all costs, including, without limitation, legal fees and
expenses, of collection, and the Holder shall be entitled to exercise all other rights and remedies available at law or in
equity.

 

Article
III. MISCELLANEOUS

 

Section
3.01 Failure or Indulgence Not Waiver. No failure or delay on the part of the Holder
in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial
exercise of any such power, right or privilege preclude other or further exercise thereof or of any other right, power or privileges.
All rights and remedies existing hereunder are cumulative to, and not exclusive of, any rights or remedies otherwise available.

 

Section
3.02 Notices. All notices, demands, requests, consents, approvals, and other communications
required or permitted hereunder shall be in writing and shall be delivered in accordance with the provisions of the Restructuring
Agreement.

 

Section
3.03 Amendments. This Note and any provision hereof may only be amended by an instrument
in writing signed by the Borrower and the Holder. The term “Note” and all reference thereto, as used throughout this
instrument, shall mean this instrument (and the other Notes issued pursuant to the Restructuring Agreement) as originally executed,
or if later amended or supplemented, then as so amended or supplemented.

 

Section
3.04 Assignability. This Note shall be binding upon the Borrower and its successors
and assigns, and shall inure to be the benefit of the Holder and its successors and assigns. Each transferee of this Note must
be an “accredited investor” (as defined in Rule 501(a) of the 1933 Act). Notwithstanding anything in this Note to
the contrary, this Note may be pledged as collateral in connection with a bona fide margin account or other lending arrangement.

 

Section
3.05 Cost of Collection. If an Event of Default occurs, the Borrower shall pay the
Holder hereof costs of collection, including reasonable attorneys’ fees.

 

Section
3.06 Governing Law.

 

	 	(a)	This
    Note shall be delivered and accepted in and shall be deemed to be contracts made under and governed by the internal laws of
    the State of Nevada, and for all purposes shall be construed in accordance with the laws of such State, without giving effect
    to the choice of law provisions of such state.

 

    	 	3	 

     

    

 

	 	(b)	Any
    action brought by either party against the other concerning the transactions contemplated by this Note shall be brought only
    in the state courts or federal courts located in the state of Texas, Dallas County. The parties to this Note hereby irrevocably
    waive any objection to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on
    lack of jurisdiction or venue or based upon forum non conveniens. The Borrower and Holder waive trial by jury. The
    prevailing party shall be entitled to recover from the other party its reasonable attorney’s fees and costs. In the
    event that any provision of this Note or any other agreement delivered in connection herewith is invalid or unenforceable
    under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict
    therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid
    or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement. Each
    party hereby irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding
    in connection with this Note by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence
    of delivery) to such party at the address in effect for notices to it under this Note and agrees that such service shall constitute
    good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any
    right to serve process in any other manner permitted by law.

 

Section
3.07 Usury Savings Clause. Notwithstanding any provision in this Note or the other
Transaction Documents to the contrary, the total liability for payments of interest and payments in the nature of interest, including,
without limitation, all charges, fees, exactions, or other sums which may at any time be deemed to be interest, shall not exceed
the limit imposed by the usury laws of the jurisdiction governing this Note or any other applicable law. In the event the total
liability of payments of interest and payments in the nature of interest, including, without limitation, all charges, fees, exactions
or other sums which may at any time be deemed to be interest, shall, for any reason whatsoever, result in an effective rate of
interest, which for any month or other interest payment period exceeds the limit imposed by the usury laws of the jurisdiction
governing this Note, all sums in excess of those lawfully collectible as interest for the period in question shall, without further
agreement or notice by, between, or to any party hereto, be applied to the reduction of the outstanding principal balance due
hereunder immediately upon receipt of such sums by the Holder hereof, with the same force and effect as though the Company had
specifically designated such excess sums to be so applied to the reduction of the principal balance then outstanding, and the
Holder hereof had agreed to accept such sums as a penalty-free payment of principal; provided, however, that the Holder may, at
any time and from time to time, elect, by notice in writing to the Company, to waive, reduce, or limit the collection of any sums
in excess of those lawfully collectible as interest, rather than accept such sums as a prepayment of the principal balance then
outstanding. It is the intention of the parties that the Company does not intend or expect to pay, nor does the Holder intend
or expect to charge or collect any interest under this Note greater than the highest non-usurious rate of interest which may be
charged under applicable law.

 

Section
3.08 Restructuring Agreement. By its acceptance of this Note, each Party agrees to
be bound by the applicable terms of the Restructuring Agreement.

 

Section
3.09 Remedies. The Borrower acknowledges that a breach by it of its obligations hereunder will cause
irreparable harm to the Holder, by vitiating the intent and purpose of the transaction contemplated hereby. Accordingly, the
Borrower acknowledges that the remedy at law for a breach of its obligations under this Note will be inadequate and agrees,
in the event of a breach or threatened breach by the Borrower of the provisions of this Note, that the Holder shall be
entitled, in addition to all other available remedies at law or in equity, and in addition to the penalties assessable
herein, to an injunction or injunctions restraining, preventing or curing any breach of this Note and to enforce specifically
the terms and provisions thereof, without the necessity of showing economic loss and without any bond or other security being
required.

 

[SIGNATURE
PAGE FOLLOWS]

 

    	 	4	 

     

    

 

IN
WITNESS WHEREOF, Borrower has caused this Note to be signed in its name by its duly authorized officer as of the Issue Date.

 

	 	Ngen Technologies Holding Corp.
	 	 	      
	 	By:	/s/
    Ed Carter
	 	Name:	Ed
    Carter
	 	Title:	Chief
    Executive Officer

 

    	 	5Exhibit
10.3

 

THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, NOR REGISTERED
OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, DELIVERED AFTER SALE, TRANSFERRED,
PLEDGED, OR HYPOTHECATED UNLESS QUALIFIED AND REGISTERED UNDER APPLICABLE STATE AND FEDERAL SECURITIES LAWS OR UNLESS, IN THE
OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY, SUCH QUALIFICATION AND REGISTRATION ARE NOT REQUIRED. ANY TRANSFER
OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE IS FURTHER SUBJECT TO OTHER RESTRICTIONS, TERMS AND CONDITIONS WHICH ARE SET
FORTH HEREIN.

 

Ngen
Technologies Holdings Corp. 

 

Warrant
for the Purchase of Shares of Common Stock

 

[Santa
Monica Venture Finance, Inc.]

 

Issue
Date: March 31, 2020

 

1,405,500
shares of Common Stock, subject to adjustment as set forth herein.

 

THIS
CERTIFIES that, for value received, Santa Monica Venture Finance, Inc., a California corporation (the “Holder”), is
entitled to subscribe for and purchase from Ngen Technologies Holdings Corp., a Nevada corporation (the “Company”),
upon the terms and conditions set forth herein, 1,405,500 shares of common stock, par value $0.001 per share (the “Common
Stock”) of the Company (which such number of shares subject to adjustment as set forth herein, the “Warrant Shares”),
at an exercise price of $0.0000071149 per Warrant Share (the “Exercise Price”), as adjusted pursuant to the provisions
herein. As used herein the term “Warrant” shall mean and include this Warrant and warrants hereafter issued as a consequence
of the exercise or transfer of this Warrant in whole or in part. The Company represents and warrants that the aggregate number
of Warrant Shares, as stated herein, is intended to represent a percentage equal to 31.52% of the total issued and outstanding
shares of the Company, as of the Issue Date, assuming, for the purposes of the calculation, the full exercise of the Warrant,
as of the Issue Date, and the inclusion of all Warrant Shares in the outstanding number of shares. In the event that, following
the Issue Date and prior to full exercise of this Warrant, the Company and the Holder determine that there are in excess of, or
less than, 3,053,620 shares of Common Stock issued and outstanding as of the Issue Date, the number of Warrant Shares for which
this Warrant is exercisable shall be automatically adjusted such that the number of Warrant Shares equals 31.52% of the total
issued and outstanding shares of the Company, as of the Issue Date, assuming, for the purposes of the calculation, the full exercise
of the Warrant, as of the Issue Date, and the inclusion of all Warrant Shares in the outstanding number of shares.

 

This
Warrant is issued to Holder pursuant to the Restructuring, Settlement and Release Agreement entered into by and between the Company,
the Holder and the other parties thereto, dated as of March 31, 2020 (the “Restructuring Agreement”) and is subject
to the terms and conditions therein. In the event of a conflict between the Restructuring Agreement and this Warrant, the terms
and conditions of this Warrant shall control.

 

    	1

    	 

    

 

	1.	Defined
    Terms. Defined terms used herein without definition have the meanings given in the Restructuring Agreement, and the following
    terms shall have the following meanings:

 

	 	(a)	“Parties”
    means the Holder and the Company.
	 	 	 
	 	(b)	“Party”
    means either the Holder or the Company, as applicable.

 

	2.	Exercise
    Period. Subject to the terms and conditions set forth herein, this Warrant may be exercised at any time or from time to
    time during the ten-year period commencing on the Issue Date as set forth above and ending of the tenth anniversary of the
    date hereof (the “Exercise Period”).
	 	 
	3.	Procedure
    for Exercise; Effect of Exercise.

 

	 	(a)	Cash
    Exercise. This Warrant may be exercised, in whole or in part, by the Holder during normal business hours on any business
    day during the Exercise Period by (i) the presentation to the Company at its principal office along of a duly executed Notice
    of Exercise (in the form attached hereto) specifying the number of Warrant Shares to be purchased (each of which shall constitute
    at least one share of Common Stock, and integral multiples thereof), and (ii) delivery of payment to the Company of the aggregate
    Exercise Price for the number of Warrant Shares being purchase as specified in the Notice of Exercise by cash, wire transfer
    of immediately available funds to a bank account specified by the Company, or by certified or bank cashier’s check.
    The Holder shall not be required to deliver the original Warrant in order to effect an exercise hereunder. Partial exercises
    of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the
    effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number
    of Warrant Shares purchased. Any fractional Warrant Shares that may be issued on exercise of this Warrant may be issued as
    such fractional shares of Common Stock, may be paid in cash or may be rounded up to the next nearest share of Common Stock,
    in each case at the election of the Company.
	 	 	 
	 	(b)	Cashless
    Exercise. Notwithstanding Section 3(a) if the “Fair Market Value” (as defined below) of one share of Common
    Stock is greater than the Exercise Price, the Holder may elect to receive Warrant Shares pursuant to a cashless exercise,
    in lieu of a cash exercise, equal to the value of this Warrant determined in the manner described below (or of any portion
    thereof remaining unexercised) by surrender of this Warrant and a Notice of Exercise, in which event the Company shall issue
    to Holder a number of Common Stock computed using the following formula:

 

X
= Y (A-B)

 

A

 

Where:

 

	 	X
    =	the
    number of Warrant Shares to be issued to Holder.
	 	 	 
	 	Y
    = 	the
    number of Warrant Shares that the Holder elects to purchase under this Warrant (at the date of such calculation).

 

    	2

    	 

    

 

	 	A
    = 	Fair
    Market Value of a Warrant Share at the date of such calculation.
	 	 	 
	 	B
    =	Exercise
    Price, as adjusted to the date of calculation.

 

For
purposes of this Warrant, the per share “Fair Market Value” shall mean (i) if the Common Stock is then listed for
trading on the OTC Markets or a United States or Canadian national securities exchange (as applicable, the “Trading Market”),
the highest traded price of the Common Stock during the twenty (20) day period during which the Common Stock is then tradeable
on the primary Trading Market prior to the date of the applicable Exercise Notice or (ii) if the Common Stock is not then listed
for trading on the OTC Markets or a United States or Canadian national securities exchange, the per share fair market value of
the Warrant Shares as is determined in good faith by the Board of Directors of the Company after taking into consideration factors
it deems appropriate, Including, without limitation, recent sale and offer prices of the capital stock of the Company in private
transactions negotiated at arm’s length.

 

	 	(c)	Effect
    of Exercise. Upon receipt by the Company of this Warrant and a Notice of Exercise, together with proper payment of the
    Exercise Price (if applicable), as provided herein, the Company agrees that such Warrant Shares shall be deemed to be issued
    to the Holder as the record holder of such Warrant Shares as of the close of business on the date on which the Notice of Exercise
    has been delivered and payment has been made for such Warrant Shares in accordance with this Warrant and the Holder shall
    be deemed to be the holder of record of the Warrant Shares, notwithstanding that the stock transfer books of the Company shall
    then be closed or that certificates representing such Warrant Shares shall not then be actually delivered to the Holder. A
    stock certificate or certificates for the Warrant Shares specified in the Notice of Exercise shall be delivered to the Holder
    as promptly as practicable, and in any event within three (3) business days, thereafter. The stock certificate(s) so delivered
    shall be in any such denominations as may be reasonably specified by the Holder in the Notice of Exercise.
	 	 	 
	 	(d)	Certain
    Adjustments. The number and kind of securities purchasable upon the exercise of this Warrant and the Exercise Price therefor
    shall be subject to adjustment from time to time upon the occurrence of certain events, as follows:

 

	 	(i)	Adjustments
    Due to Splits and Stock Dividends. If at any time while this Warrant is outstanding, the Company: (x) pays a dividend
    or makes any other distribution upon the shares, or any other securities of the Company, payable in shares, convertible securities
    or equity-linked securities of the Company, or (y) effects a forward split or reverse split of the Common Stock, which shall
    include a recapitalization, combination or otherwise, the number of Warrant Shares shall be appropriately adjusted, with any
    partial resulting Warrant Share being rounded up to the next nearest whole number, and the Exercise Price shall be proportionately
    adjusted such that the aggregate Exercise Price payable hereunder shall remain unchanged. By way of example and not limitation,
    (i) in the event that the Company effects a two-for-one forward split of the Common Stock, wherein each issued and outstanding
    share of Common Stock is converted into two shares of Common Stock, the number of Warrant Shares shall be doubled and the
    Exercise Price shall be reduced by 50% and (ii) in the event that the Company effects a one-for-two reverse split of the Common
    Stock, wherein each two issued and outstanding shares of Common Stock are converted into one share of Common Stock, the number
    of Warrant Shares shall be reduced by 50% and the Exercise Price shall be doubled.

 

    	3

    	 

    

 

	 	(ii)	Adjustments
    Due to Share Issuances. In at any time while this Warrant is outstanding, the Company issues any shares of Common Stock
    upon conversion of any promissory notes, exercise of warrants or other convertible or equity-linked securities, which in each
    case are issued and outstanding as of the Issue Date as set forth above and which are held by any of Carebourn Capital, LP,
    a Delaware Limited Partnership (“CareBourn LP”), CareBourn, LLC, a Nevada limited liability company (“CareBourn
    LLC”), More Capital LLC, a Minnesota limited liability company (“More Capital”), or Auctus Fund, LLC, a
    Delaware limited liability company (“Auctus”), then the number of Warrant Shares shall be appropriately adjusted
    to add a number of Warrant Shares hereunder equal to (i) the number of shares of Common Stock issued CareBourn LP, CareBourn
    LLC, More Capital or Auctus, as applicable, multiplied by (ii) 46%. By way of example and not limitation, in the event that
    CareBourn LP exercises a warrant referenced above and acquires 100 shares of Common Stock thereunder, this Warrant shall be
    automatically adjustment to add 46 Warrant Shares to the total number of Warrant Shares which may be acquired hereunder, with
    the intent that Holder retains the right to acquire 31.52% of the issued and outstanding shares of Common Stock at such time.
    The Company represents and warrants none of the securities held by CareBourn LP, CareBourn LLC, More Capital and Auctus entitle
    the holder to receive any dividends or distributions from the Company unless the security is first converted into shares of
    Common Stock. The Company further represents and warrants that, as of the Issue Date, the only class of stock of the Company
    that is issued and outstanding is Common Stock. 
	 	 	 
	 	(iii)	Fundamental
    Transactions. In the event that, prior to any exercise hereunder, the Common Stock is converted into another class of
    securities of the Company or any successor entity to the Company, whether by way of merger, reorganization, re- incorporation
    or otherwise (the “Replacement Securities”), any reference herein to the Common Stock (whether standing alone
    or as part of another defined term herein) automatically upon the consummation of the applicable transaction shall be deemed
    a reference to such Replacement Securities. In the event that, prior to any exercise hereunder, the Company completes a share
    exchange with another entity wherein all of the issued and outstanding shares of Common Stock are exchanged for equity interests
    in the other entity (the “Exchanged Securities”), any reference herein to the Common Stock (whether standing alone
    or as part of another defined term herein) automatically upon the consummation of the applicable transaction shall be deemed
    a reference to such Exchanged Securities. Then, upon any subsequent exercise of this Warrant, the Holder shall have the right
    to receive the number of Replacement Securities or Exchanged Securities and any additional consideration (the “Alternate
    Consideration”) receivable upon or as a result of such merger, reorganization, re-incorporation or exchange as receivable
    for the Warrant Shares had they been issued at that time, with appropriate and equitable adjustments being made to the Exercise
    Price, and for purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply
    to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common
    Stock.

 

    	4

    	 

    

 

	 	(iv)	Notice
    of Adjustments. Whenever the number of Warrant Shares purchasable hereunder or the Exercise Price thereof shall be adjusted
    pursuant hereto, the Company shall provide notice to the Holder setting forth, in reasonable detail, the event requiring the
    adjustment, the amount of the adjustment, the method by which such adjustment was calculated, and the number and class of
    shares which may be purchased thereafter and the Exercise Price therefor after giving effect to such adjustment.

 

	 	(e)	Holder’s
    Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right
    to exercise any portion of this Warrant, to the extent that after giving effect to the conversion set forth on the applicable
    Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other Persons acting as a group together
    with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)) would beneficially
    own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number
    of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
    of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but
    shall exclude the number of shares of Common Stock which are issuable upon (i) exercise of the remaining, non-exercised portion
    of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
    of the unexercised or unconverted portion of any other securities of the Company subject to a limitation on conversion or
    exercise analogous to the limitation contained herein (including, without limitation, the Note or any other Warrants) beneficially
    owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes
    of this Section 3(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act, and the
    rules and regulations promulgated thereunder. To the extent that the limitation contained in this Section 3(e) applies, the
    determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any
    Affiliates and Attribution Parties) and of which this Warrant is exercisable shall be in the sole discretion of the Holder,
    and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination of whether this Warrant
    may be exercised (in relation to other securities owned by the Holder together with any Affiliates or Attribution Parties)
    and which portion of this Warrant may be exercised, in each case subject to the Beneficial Ownership Limitation. To ensure
    compliance with this restriction, the Holder will be deemed to represent to the Company each time it delivers a Notice of
    Exercise that such Notice of Exercise has not violated the restrictions set forth in this Section 3(e) and the Company shall
    have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
    as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
    promulgated thereunder. For purposes of this Section 3(e) in determining the number of outstanding shares of Common Stock,
    the Holder may rely on the number of outstanding shares of Common Stock as stated in the most recent of the following: (i)
    the Company’s most recent periodic or annual report filed with the SEC, as the case may be, (ii) a more recent public
    announcement by the Company, or (iii) a more recent written notice by the Company or the Company’s transfer agent setting
    forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within
    one Business Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any
    case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise
    of securities of the Company, including this Warrant, by the Holder or its Affiliates since the date as of which such number
    of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 9.99% of the
    number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable
    upon exercise of this Warrant by the Holder. The Holder, upon notice to the Company, may increase or decrease the Beneficial
    Ownership Limitation provisions of this Section 3(e) provided that any increase in the Beneficial Ownership Limitation will
    not be effective until the 61st day after such notice is delivered to the Company. The Beneficial Ownership Limitation
    provisions of this Section 3(e) shall be construed and implemented in a manner otherwise than in strict conformity with the
    terms of this Section 3(e) to correct this Section 3(e) (or any portion hereof) which may be defective or inconsistent with
    the intended Beneficial Ownership Limitation contained herein or to make changes or supplements necessary or desirable to
    properly give effect to such limitation. The limitations contained in this Section 3(e) shall apply to a successor holder
    of this Warrant.

 

    	5

    	 

    

 

	 	(f)	Conditional
    Exercise. Notwithstanding any other provision hereof, if an exercise of any portion of this Warrant is to be made in connection
    with a public offering or a sale of the Company (pursuant to a merger, sale of securities or assets, or otherwise), such exercise
    may at the election of the Holder be conditioned upon the consummation of such transaction, in which case such exercise shall
    not be deemed to be effective until immediately prior to the consummation of such transaction.

 

	4.	Notices.
    In the event that, at any time while this Warrant is outstanding:

 

	 	(i)	the
    Company shall take a record of the holders of its shares for the purpose of entitling or enabling them to receive any dividend
    or other distribution, to vote at a meeting (or by written consent), to receive any right to subscribe for or purchase any
    securities, or to receive any other security;
	 	 	 
	 	(ii)	the
    Company shall undertake any capital reorganization of the Company, any reclassification of the shares of the Company, any
    consolidation or merger of the Company with or into another Person, or sale of all or substantially all of the Company’s
    assets to another Person; or
	 	 	 
	 	(iii)	 the
    Company shall undertake any voluntary or involuntary dissolution, liquidation or winding-up of the Company;

 

then,
and in each such case, the Company shall send or cause to be sent to the Holder at least thirty (30) days prior to the applicable
record date or the applicable expected effective date, as the case may be, for the event, a written notice specifying, as the
case may be, (A) the record date for such dividend, distribution, meeting or consent or other right or action, and a description
of such dividend, distribution or other right or action to be taken at such meeting or by written consent, or (B) the effective
date on which such reorganization, reclassification, consolidation, merger, sale, dissolution, liquidation or winding-up is proposed
to take place, and the date, if any is to be fixed, as of which the books of the Company shall close or a record shall be taken
with respect to which the holders of record of the shares (or shares issuable upon exercise of the Warrant at that time) shall
be entitled to exchange their shares (or such other securities) for securities or other property deliverable upon such reorganization,
reclassification, consolidation, merger, sale, dissolution, liquidation or winding-up, and the amount per unit and character of
such exchange applicable to the Warrant and the Warrant Shares.

 

    	6

    	 

    

 

	5.	Registration
    of Warrants; Transfer of Warrants. Any Warrants issued upon the transfer or exercise in part of this Warrant shall be
    numbered and shall be registered in a Warrant Register as they are issued. The Company shall be entitled to treat the registered
    holder of any Warrant on the Warrant Register as the owner in fact thereof for all purposes and shall not be bound to recognize
    any equitable or other claim to or interest in such Warrant on the part of any other person, and shall not be liable for any
    registration or transfer of Warrants which are registered or to be registered in the name of a fiduciary or the nominee of
    a fiduciary unless made with the actual knowledge that a fiduciary or nominee is committing a breach of trust in requesting
    such registration or transfer, or with the knowledge of such facts that its participation therein amounts to bad faith. This
    Warrant shall be transferable only on the books of the Company upon delivery thereof duly endorsed by the Holder or by its
    duly authorized attorney or representative, or accompanied by proper evidence of succession, assignment, or authority to transfer.
    In all cases of transfer by an attorney, executor, administrator, guardian, or other legal representative, duly authenticated
    evidence of his or its authority shall be produced. Upon any registration of transfer, the Company shall deliver a new Warrant
    or Warrants to the person entitled thereto. This Warrant may be exchanged, at the option of the Holder thereof, for another
    Warrant, or other Warrants of different denominations, of like tenor and representing in the aggregate the right to purchase
    a like number of Warrant Shares, upon surrender to the Company or its duly authorized agent.
	 	 
	6.	Restrictions
    on Transfer.

 

	 	(a)	The
    Holder, as of the Issuance Date, represents to the Company that such Holder is acquiring this Warrant for its own account
    for investment purposes and not with a view to the distribution thereof or of the Warrant Shares. Notwithstanding any provisions
    contained in this Warrant to the contrary, this Warrant, or any portion thereof, and the related Warrant Shares shall not
    be transferable except pursuant to the proviso contained in the following sentence or upon the conditions specified in this
    Section 6, which conditions are intended, among other things, to insure compliance with the provisions of the Securities Act
    of 1933, as amended (the “Securities Act”) and applicable state law in respect of the transfer of this Warrant
    or such Warrant Shares. The Holder by acceptance of this Warrant agrees that the Holder will not transfer this Warrant or
    the related Warrant Shares prior to delivery to the Company of an opinion of the Holder’s counsel (as such opinion and
    such counsel are described in Section 6(b)) or until registration of such Warrant Shares under the Securities Act has become
    effective or after a sale of such Warrant or Warrant Shares has been consummated pursuant to Rule 144 or Rule 144A under the
    Securities Act; provided, however, that the Holder may freely transfer this Warrant, any portion thereof, or such Warrant
    Shares (without delivery to the Company of an opinion of counsel) (i) to one of its nominees, affiliates (which shall include
    Yaakov G. Vanek or Eric J. Weissman) or a nominee thereof, (ii) from a nominee to any of the aforementioned persons as beneficial
    owner of this Warrant or such Warrant Shares, (iii) to a qualified institutional buyer, so long as such transfer is effected
    in compliance with Rule 144A under the Securities Act, or (iv) to an accredited investor (as such term is defined in Regulation
    D under the Securities Act).

 

    	7

    	 

    

 

	 	(b)	The
    Holder, by its acceptance hereof, agrees that prior to any transfer of this Warrant or of the related Warrant Shares (other
    than as permitted by Section 6(a) or pursuant to a registration under the Securities Act), the Holder will give written notice
    to the Company of its intention to effect such transfer, together with an opinion of such counsel for the Holder as shall
    be reasonably acceptable to the Company, to the effect that the proposed transfer of this Warrant and/or such Warrant Shares
    may be effected without registration under the Securities Act. Upon delivery of such notice and opinion, if required, to the
    Company, the Holder shall be entitled to transfer this Warrant and/or such Warrant Shares in accordance with the intended
    method of disposition specified in the notice to the Company and the Company shall execute and deliver a new Warrant or Warrants
    in the name of the assignee or assignees and in the denominations specified in such instrument of assignment, and shall issue
    to the assignor a new Warrant evidencing the portion of this Warrant, if any, not so assigned and this Warrant shall promptly
    be cancelled.
	 	 	 
	 	(c)	Upon
    any transfer of this Warrant, the Company shall issue a replacement warrant to the transferee (the “Replacement Warrant”)
    which shall have provisions providing to the transferee the same economic interest in the Warrant Shares and otherwise having
    tenor herein, but which Replacement Warrant the Company and the Holder agree shall not be connected or linked to the Restructuring
    Agreement and shall be a standalone customary warrant agreement, in form and substance as reasonably agreed to by the Company
    and the Holder. By way of example and not limitation, the provisions of Section 11, Section 14, Section 16(a) and Section
    16(f) shall be appropriately revised in the Replacement Warrant. Upon any issuance of a Replacement Warrant, this Warrant
    shall also be amended to reduce the number of Warrant Shares exercisable hereunder. 
	 	 	 
	 	(d)	Each
    stock certificate representing Warrant Shares issued upon exercise or exchange of this Warrant shall bear the following legend
    unless the opinion of counsel referred to in Section 6(a) states such legend is not required:

 

“THIS
SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE
UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY,
MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE
EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
APPLICABLE STATE SECURITIES LAWS. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED
BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a)
UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.”

 

	7.	Reservation
    of Shares; Reissuance. The Company shall at all times during the Exercise Period reserve and keep available out of its
    authorized and unissued Common Stock, solely for the purpose of providing for the exercise of the rights to purchase all Warrant
    Shares granted pursuant to the Warrants, such number of shares of Common Stock as shall, from time to time, be sufficient
    therefor. The Company covenants that all shares of Common Stock issuable upon exercise of this Warrant, upon receipt by the
    Company of the full Exercise Price therefor, shall be validly issued, fully paid, non-assessable, and free of preemptive rights,
    and free from all taxes, claims, liens, charges and other encumbrances. If this Warrant is lost, stolen, mutilated or destroyed,
    the Company will, on such terms as to indemnity or otherwise as it may reasonably impose (which shall, in the case of a mutilated
    Warrant, include the surrender thereof), issue a new Warrant of like denomination and tenor as this Warrant so lost, stolen,
    mutilated or destroyed. In the event that this Warrant is not fully exercised by the end of the Exercise Period it shall thereafter
    be void and of no further force and effect.

 

    	8

    	 

    

 

	8.	No
    Impairment and Non-Circumvention. The Company shall not, by amendment of its articles of incorporation or bylaws, or through
    any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities, or any other voluntary
    action, avoid, or seek to avoid, the observance or performance of any of the terms to be observed or performed by it hereunder.
    The Company shall at all times in good faith assist in the carrying out of all the provisions of this Warrant and in the taking
    of all such action as may reasonably be requested by the Holder in order to protect the rights of the Holder, including, but
    not limited to, providing the Holder with the Company’s and its subsidiaries’ financial information. 
	 	 
	9.	Transfer
    Taxes. The issuance of any shares or other securities upon the exercise of this Warrant, and the delivery of certificates
    or other instruments representing such shares or other securities, shall be made without charge to the Holder (or its nominees
    or affiliates as defined above) for any tax or other charge in respect of such issuance. The Company shall not, however, be
    required to pay any tax which may be payable in respect of any transfer involved in the issue and delivery of any certificate
    in a name other than that of the above referenced persons and the Company shall not be required to issue or deliver any such
    certificate unless and until the person or persons requesting the issue thereof shall have paid to the Company the amount
    of such tax or shall have established to the satisfaction of the Company that such tax has been paid.
	 	 
	10.	Holder
    Not Deemed a Shareholder; No Liability. Prior to the issuance to the Holder of the Warrant Shares to which the Holder
    is then entitled to receive upon the due exercise of this Warrant, the Holder shall not be deemed the holder of shares of
    the Company for any purpose (unless the Holder otherwise holds shares of the Company independent of this Warrant). In addition,
    subject to the provision in the foregoing sentence, nothing contained in this Warrant shall be construed as imposing any liabilities
    on the Holder: (i) as a shareholder of the Company, whether such liabilities are asserted by the Company or by any other person,
    including creditors of the Company, or (ii) to purchase any securities (by exercise of this Warrant or otherwise).
	 	 
	11.	Resolution
    of Disputes. Any dispute, claim, or controversy arising out of or relating to this Warrant (including with respect to
    the meaning, effect, validity, termination, interpretation, performance, or enforcement of this Warrant) or any alleged breach
    thereof (including any action in tort, contract, equity, or otherwise), shall be resolved in accordance with the “Resolution
    of Disputes” provision of the Restructuring Agreement.
	 	 
	12.	Governing
    Law; Consent to Jurisdiction. This Warrant shall be governed, construed and enforced in accordance with the Laws of the
    State of Nevada, without application of the conflicts of laws provisions thereof. Subject to Section 11, each Party agrees
    that all legal proceedings concerning the interpretation, enforcement and defense of the transactions contemplated by this
    Warrant (whether brought against a Party hereto or its respective Affiliates, directors, officers, shareholders, employees
    or agents) shall be commenced in the state and federal courts sitting in Dallas County, Texas (the “Selected Courts”).
    Each Party hereto hereby irrevocably submits to the exclusive jurisdiction of the Selected Courts for the adjudication of
    any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby
    irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject
    to the jurisdiction of such Selected Courts, or such Selected Courts are improper or inconvenient venue for such proceeding.
    Each Party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action
    or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
    to such Party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute
    good and sufficient service of process and notice thereof.

 

    	9

    	 

    

 

	13.	Waiver
    of Jury Trial; Exemplary Damages. 

 

	 	(a)	EACH
    PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN
    ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED
    HEREIN (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT
    OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION,
    SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER
    INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 13(a).
	 	 	 
	 	(b)	Each
    of the Parties acknowledge that each has been represented in connection with the signing of the waiver set forth in Section
    13(a) by independent legal counsel selected by the respective Party and that such Party has discussed the legal consequences
    and import of such waiver with legal counsel. Each of the Parties further acknowledge that each has read and understands the
    meaning of such waiver and grants such waiver knowingly, voluntarily, without duress and only after consideration of the consequences
    of this waiver with legal counsel.
	 	 	 
	 	(c)	IN
    NO EVENT WILL ANY PARTY BE LIABLE TO ANY OTHER PARTY UNDER OR IN CONNECTION WITH THIS WARRANT OR IN CONNECTION WITH THE TRANSACTIONS
    CONTEMPLATED HEREIN FOR SPECIAL, GENERAL, INDIRECT, CONSEQUENTIAL, OR PUNITIVE OR EXEMPLARY DAMAGES, INCLUDING DAMAGES FOR
    LOST PROFITS OR LOST OPPORTUNITY, EVEN IF THE PARTY SOUGHT TO BE HELD LIABLE HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE.

 

	14.	Indemnification.
    The Company and the Holder agree that the indemnification provisions of the Restructuring Agreement shall apply to this
    Warrant.
	 	 
	15.	Specific
    Performance. The Parties agree that irreparable damage would occur in the event that any of the provisions of this Warrant
    were not performed by them in accordance with the terms hereof or were otherwise breached and that each Party hereto shall
    be entitled to an injunction or injunctions, specific performance and other equitable relief to prevent breaches of the provisions
    hereof and to enforce specifically the terms and provisions hereof, without the proof of actual damages, in addition to any
    other remedy to which they are entitled at law or in equity. Each Party agrees to waive any requirement for the security or
    posting of any bond in connection with any such equitable remedy, and agrees that it will not oppose the granting of an injunction,
    specific performance or other equitable relief on the basis that (a) the other Party has an adequate remedy at law, or (b)
    an award of specific performance is not an appropriate remedy for any reason at law or equity.

 

    	10

    	 

    

 

	16.	Miscellaneous.

 

	 	(a)	Notices.
    Any notice or other communications required or permitted hereunder shall be given in accordance with the terms and conditions
    of the Restructuring Agreement.
	 	 	 
	 	(b)	Absolute
    Obligation. Except as expressly provided herein, no provision of this Warrant shall alter or impair the obligations of
    the Company, which are absolute and unconditional.
	 	 	 
	 	(c)	Lost
    or Mutilated Warrant. If this Warrant shall be mutilated, lost, stolen or destroyed, the Company shall execute and deliver,
    in exchange and substitution for and upon cancellation of a mutilated Warrant, or in lieu of or in substitution for a lost,
    stolen or destroyed Warrant, a new Warrant so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such
    loss, theft or destruction of this Warrant, and of the ownership hereof reasonably satisfactory to the Company.
	 	 	 
	 	(d)	Attorneys’
    Fees. In the event that any Party institutes any action or suit to enforce this Warrant or to secure relief from any default
    hereunder or breach hereof, the prevailing Party shall be reimbursed by the losing Party for all costs, including reasonable
    attorney’s fees, incurred in connection therewith and in enforcing or collecting any judgment rendered therein.
	 	 	 
	 	(e)	Severability.
    If any term or provision of this Warrant is held by a court of competent jurisdiction or other authority to be invalid, void
    or unenforceable in any situation in any jurisdiction, such determination shall not affect the validity or enforceability
    of the remaining terms and provisions hereof or thereof or the validity or enforceability of the offending term or provision
    in any other situation or in any other jurisdiction. If the final judgment of a court of competent jurisdiction or other authority
    declares that any term or provision hereof or thereof is invalid, void or unenforceable, each of the Company and the Holder
    agrees that the court making such determination shall have the power to reduce the scope, duration, area or applicability
    of the term or provision; to delete specific words or phrases; or to replace any invalid, void or unenforceable term or provision
    with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid,
    void or unenforceable term or provision.
	 	 	 
	 	(f)	Entire
    Agreement. This Warrant and the other Transaction Documents constitute the entire agreement between the Parties with respect
    to the subject matter hereof and thereof and supersede all prior agreements, understandings and negotiations, whether written
    or oral, of the Parties.

 

    	11

    	 

    

 

	 	(g)	Arm’s
    Length Bargaining; No Presumption Against Drafter. This Warrant has been negotiated at arm’s-length by parties of
    equal bargaining strength, each represented by counsel or having had but declined the opportunity to be represented by counsel
    and having participated in the drafting of this Warrant. This Warrant creates no fiduciary or other special relationship between
    the Parties, and no such relationship otherwise exists. No presumption in favor of or against any Party in the construction
    or interpretation of this Warrant or any provision hereof shall be made based upon which Person might have drafted this Warrant
    or such provision.
	 	 	 
	 	(h)	Amendment;
    Waiver. Other than as specifically set forth herein, this Warrant may be amended, and the observance of any term hereof
    may be waived (either retroactively or prospectively), only upon the written consent of the Company and the Holder.
	 	 	 
	 	(i)	Descriptive
    Headings. The descriptive headings herein are inserted for convenience of reference only and shall in no way be construed
    to define, limit, describe, explain, modify, amplify, or add to the interpretation, construction or meaning of any provision
    of, or scope or intent of, this Warrant nor in any way affect this Warrant.
	 	 	 
	 	(j)	Third
    Party Beneficiaries. This contract is strictly between the Parties and, except as specifically provided, no other Person
    and no director, officer, shareholder, employee, agent, independent contractor or any other Person shall be deemed to be a
    third-party beneficiary of this Warrant.
	 	 	 
	 	(k)	Currency.
    All dollar amounts are in U.S. dollars.

 

[SIGNATURE
PAGE FOLLOWS]

 

    	12

    	 

    

 

Issuance
date: March 31, 2020

 

	 	Ngen
    Technologies Holdings Corp.
	 	 	 
	 	By:	/s/
    Ed Carter
	 	Name:	Ed
    Carter
	 	Title:	Chief
    Executive Officer

 

    	13

    	 

    

 

NOTICE
OF EXERCISE

 

	To:	Ngen
    Technologies Holdings Corp. 
	 	 
	 	Attention:
    Chief Executive Officer

 

THE
UNDERSIGNED holder hereby exercises the right to purchase______________of the shares of Common Stock (“Warrant Shares”) of Ngen
Technologies Holdings Corp., a Nevada corporation (the “Company”), evidenced by the attached copy of the Warrant to
Purchase Shares of Common Stock (the “Warrant”). Capitalized terms used herein and not otherwise defined shall have
the respective meanings set forth in the Warrant.

 

	1.	Form
    of Exercise Price. The Holder intends that payment of the Exercise Price shall be made as (check one):

 

	 	[  ]	a
    cash exercise with respect to___________________Warrant Shares; or
	 	 	 
	 	[  ]	by
    cashless exercise pursuant to the Warrant.

 

	2.	Payment
    of Exercise Price. If cash exercise is selected above, the holder shall pay the applicable aggregate Exercise Price in
    the sum of $________________________to the Company in accordance with the terms of the Warrant.
	 	 
	3.	Delivery
    of Warrant Shares. The Company shall deliver to the holder___________________Warrant Shares, to:

 

(Print
Name, Address and Social Security or Tax Identification Number)

 

 

 

 

 

 

 

 

 

 

 

If
such number of Warrant Shares shall not be all the Warrant Shares covered by the within Warrant, a new Warrant for the balance
of the Warrant Shares covered by the within Warrant be registered in the name of, and delivered to, the undersigned at the address
stated above.

 

	Dated:	 	 
	 	 	 
	Name:	 	 
	 	 	 
	By:	 	 
	Name:	 	 
	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}]]